Mammoth in-licenses CRISPR-Cas14 IP

Mammoth exclusively licensed IP covering one of the newest families of CRISPR enzymes, Cas14, from the University of California Berkeley. The new license adds a third group of CRISPR enzymes to the diagnostics company's toolbox.

While the IP landscape covering CRISPR-Cas9 for therapeutic

Read the full 421 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE